Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

BIOTRONIK Announces Six-Month Coronary Stenting ENERGY Registry Results Presented at TCT 2011

November 15, 2011 By AxoGen, Inc.

BUELACH, Switzerland–(BUSINESS
WIRE
)–BIOTRONIK AG announced that the six-month results of the
ENERGY Registry were presented last week by Prof. Raimund Erbel at the Transcatheter Cardiovascular Therapeutics (TCT 2011)
conference. This all-comers registry is investigating the safety and clinical
performance of the PRO-Kinetic Energy stent system in 1016 patients, including
a subanalysis with small vessels, diabetic and elderly patients.

“We are delighted that the ENERGY Registry supports our
belief that the PRO-Kinetic Energy stent is an excellent platform. For years we
have invested in continued development in our stent platforms, and these
outstanding results are a testament to our dedication.”

The ENERGY registry was conducted in 49 sites in 10
countries with patients who received a PRO-Kinetic Energy coronary bare metal
stent. The study population included a high number of patients with acute coronary syndrome (46%), almost 30% elderly patients
(?75 years), as well as highly complex lesions (39%). The primary endpoint was
six-month major adverse coronary events (MACE) defined as a composite of
cardiac death, clinically driven target lesion revascularization (TLR) and
myocardial infarction.

At six months, the PRO-Kinetic Energy stent system
demonstrated excellent clinical outcomes, with a MACE rate of only 4.4%.
Cardiac death, myocardial infarction, target lesion revascularization rates
were 0.6%, 1.3% and 2.5%, respectively. Only two cases of stent thrombosis
(0.2%) were seen. Also, in the small vessel (?2.75 mm) population, the very low
number of events was confirmed with a MACE rate of 6.4% and a TLR of only 2.8%.

“For the treatment of coronary artery lesions, it is crucial
to have a bare metal stent available that is not only highly deliverable, but
also safe and effective in a broad patient population-including elderly
patients and those presenting with acute coronary syndrome, stated Prof.
Raimund Erbel, principal investigator from the West German Heart Center in
Essen, Germany. “These six-month results are excellent.”

Alain Aimonetti, Vice President of Marketing and Sales at
BIOTRONIK AG added, “We are delighted that the ENERGY Registry supports our
belief that the PRO-Kinetic Energy stent is an excellent platform. For years we
have invested in continued development in our stent platforms, and these
outstanding results are a testament to our dedication.”

The PRO-Kinetic Energy is a thin strut (60?m), cobalt
chromium bare metal stent, completely sealed with a thin layer of amorphous
silicon carbide, PROBIO. This passive coating reduces the interaction between
the metal stent and the surrounding tissue, which makes the stent more
hemocompatible.

About BIOTRONIK SE & Co. KG

As one of the worlds leading cardiovascular medical device companies, with
several million implanted devices, BIOTRONIK is represented in over 100
countries with its global workforce of more than 5100 employees. Known for
having its finger on the pulse of the medical community, BIOTRONIK assesses the
challenges physicians face, and provides the best solutions for all phases of
patient care, ranging from diagnosis to treatment to patient management.
Quality, innovation and reliability define BIOTRONIK and its growing
success-and deliver confidence and peace of mind to physicians and their
patients worldwide. More information: www.biotronik.com

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech